|
|
Volumn 289, Issue 5478, 2000, Pages
|
|
Alzheimer's congress: Drug shows promise for advanced disease
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MEMANTINE;
AMINO ACID RECEPTOR BLOCKING AGENT;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
ALZHEIMER DISEASE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE COURSE;
DRUG EFFICACY;
DRUG MARKETING;
DRUG MECHANISM;
HUMAN;
META ANALYSIS;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ANTAGONISM;
METABOLISM;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
UNITED STATES;
ALZHEIMER DISEASE;
DISEASE PROGRESSION;
EXCITATORY AMINO ACID ANTAGONISTS;
HUMANS;
MEMANTINE;
RECEPTORS, N-METHYL-D-ASPARTATE;
UNITED STATES;
|
|
EID: 0034697903
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.289.5478.375b Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (0)
|